LLY

ELI LILLY & Co

Health Care · Pharmaceuticals

$82.71 sample

-1.18 (-1.41%) 1D

Market cap

$43.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-08

Alerts

8

Price$82.71 +6.28% 3M daily closessample

91.1677.82

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: General Counsel
Oct 08SEC10-Q filed
Oct 01SECForm 144 filed
Sep 25INSInsider buy: Chief Executive Officer
Sep 21INSInsider sell: Director
Sep 11INSInsider sell: Chief Financial Officer
Sep 02INSInsider sell: 10% owner
Aug 24INSInsider sell: General Counsel

Sign up to see the real LLY record →

Company facts

SEC EDGAR registration

Name: ELI LILLY & Co
Sector: Health Care
Industry: Pharmaceuticals
Smart-money score: +37sample, -100 to +100
Reporting currency: USD

Who is positioning in LLY

sample

Insiders: 33 insider transactions over 90 days, net selling, $39.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 43 funds hold $516.9M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$1.2B +18.8% y/y

Q4 2024Q3 2026

Inventory$667.1M +3.8% y/y

Q4 2024Q3 2026

Accounts receivable$536.1M +19.8% y/y

Q4 2024Q3 2026

Total debt$1.4B +11.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $41.4B -9.5% 3M
Sample peer B: $26.6B -12.2% 3M
Sample peer C: $43.4B -3.6% 3M
Sample peer D: $6.1B +13.9% 3M
Sample peer E: $31.4B -12.0% 3M